![]()
34
| 1 | 2008
Klinisk Biokemi i Norden
(Fortsat fra side 32)
Vlassov VV. Cell-surface-bound nucleic acids:
Free and cell-surface-bound nucleic acids in
blood of healthy donors and breast cancer
patients. Ann N Y Acad Sci 2004;1022:221-7.
39. Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC,
Wong SC et al. Presence of filterable and
nonfilterable mRNA in the plasma of cancer
patients and healthy individuals. Clin Chem
2002;48:1212-7.
40. Lo YM, Corbetta N, Chamberlain PF, Rai
V, Sargent IL, Redman CW, Wainscoat JS.
Presence of fetal DNA in maternal plasma and
serum. Lancet 1997;350:485-7.
41. Tsui NB, Chim SS, Chiu RW, Lau TK, Ng
EK, Leung TN et al. Systematic micro-array
based identification of placental mRNA in
maternal plasma: towards non-invasive pre-
natal gene expression profiling. J Med Genet
2004;41:461-7.
42. Ryan BM, Lefort F, McManus R, Daly J, Keeling
PW, Weir DG, Kelleher D. A prospective study
of circulating mutant KRAS2 in the serum
of patients with colorectal neoplasia: strong
prognostic indicator in postoperative follow
up. Gut 2003;52:101-8.
43. Pornthanakasem
W,
Shotelersuk
K,
TermrungruanglertW, VoravudN, Niruthisard
S, Mutirangura A. Human papillomavirus
DNA in plasma of patients with cervical can-
cer. BMC Cancer 2001;1:2.
44. Kopreski MS, Benko FA, Kwak LW, Gocke CD.
Detection of tumor messenger RNA in the
serum of patients with malignant melanoma.
Clin Cancer Res 1999;5:1961-5.
45. Hasselmann DO, Rappl G, Tilgen W, Reinhold
U. Extracellular tyrosinase mRNA within
apoptotic bodies is protected from degradation
in human serum. Clin Chem 2001;47:1488-9.
46. Lledo SM, Garcia-Granero E, Dasi F, Ripoli R,
Garcia SA, Cervantes A, Alino SF. Real time
quantification in plasma of human telomer-
ase reverse transcriptase (hTERT) mRNA in
patients with colorectal cancer. Colorectal Dis
2004;6:236-42.
47. Goebel G, Zitt M, Zitt M, Muller HM.
Circulating nucleic acids in plasma or serum
(CNAPS) as prognostic and predictive markers
in patients with solid neoplasias. Dis Markers
2005;21:105-20.
48. Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T et
al. Presence of erbB2 mRNA in the plasma of
breast cancer patients is associated with circu-
lating tumor cells and negative estrogen and
progesterone receptor status. Breast Cancer
Res Treat 2005;1-7.
49. Bustin SA, Nolan T. Pitfalls of quantitative
real-time reverse-transcription polymerase
chain reaction. J Biomol Tech 2004;15:155-66.
50. Haug KBF, Ovstebo R, Kierulf P. How to moni-
tor gene expression. NBS-nytt 2003;4:21-5.
51. Wittwer CT, Herrmann MG, Moss AA,
Rasmussen RP. Continuous fluorescence
monitoring of rapid cycle DNA amplification.
Biotechniques 1997;22:130-8.
52. Ovstebo R, Haug KBF, Lande K, Kierulf P.
PCR-based calibration curves for studies of
quantitative gene expression in human mono-
cytes: Development and evaluation. Clinical
Chemistry 2003;49:425-32.
53. ABI Prism 7900HT sequence Detection
System and SDS Enterprise Database; User
Guide. Basic Operation and Maintenance.
2002. Applied Biosystems.
54. Ririe KM, Rasmussen RP, Wittwer CT. Product
differentiation by analysis of DNA melting
curves during the polymerase chain reaction.
Anal Biochem 1997;245:154-60.
55. Watson A, Mazumder A, Stewart M,
Balasubramanian S. Technology for microar-
ray analysis of gene expression. Curr Opin
Biotechnol 1998;9:609-14.
56. Kennedy GC, Matsuzaki H, Dong S, Liu
WM, Huang J, Liu G et al. Large-scale gen-
otyping of complex DNA. Nat Biotechnol
2003;21:1233-7.
57. Churchill GA. Fundamentals of experimen-
tal design for cDNA microarrays. Nat Genet
2002;32 Suppl:490-5.
58. Hughes TR, Mao M, Jones AR, Burchard J,
Marton MJ, Shannon KW et al. Expression
profiling using microarrays fabricated by
an ink-jet oligonucleotide synthesizer. Nat
Biotechnol 2001;19:342-7.
